Bayer seeks EU approval of Eylea for DME

Bayer AG (Xetra:BAYN) submitted an application to EMA to expand the European label of Eylea aflibercept to include diabetic macular edema (DME). On Tuesday, partner Regeneron Pharmaceuticals Inc. (NAS...